Analysis of genomic imprinting at 1p35-36 in neuroblastoma
- PMID: 11464906
- DOI: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8
Analysis of genomic imprinting at 1p35-36 in neuroblastoma
Abstract
Background: Deletion of the distal short arm of chromosome 1 occurs in 25-35% of primary neuroblastomas, and a putative tumor suppressor gene has been mapped to a consensus region of deletion at 1p36.2-36.3. Indirect evidence suggests the presence of an imprinted neuroblastoma suppressor gene within this region, as well as an additional nonimprinted, proximal suppressor gene, inactivation of which correlates with MYCN amplification.
Procedure: To test this hypothesis, we performed 1p loss of heterozygosity (LOH) studies on a series of neuroblastomas for which parental DNA had been collected. PCR-formatted polymorphic markers were used to determine the size of the 1p deletion and the parental origin of the deleted 1p homologue.
Results: Twenty-six neuroblastomas with 1p LOH were evaluated. Twenty-four had MYCN amplification, and of these, 15 demonstrated loss of the paternally inherited 1p. Two neuroblastomas with a single copy of MYCN were evaluated and both had deletion of the paternally inherited 1p, with one case exhibiting a small terminal deletion. In addition, we have reviewed 49 previously reported neuroblastomas where 1p LOH data and the parental origin of the deleted lp homologue were available.
Conclusions: Analyzed together, these 75 neuroblastomas demonstrate random deletion of parental 1p homologues (P = 0.30). Further, tumors with smaller deletions (breakpoints distal to D1S201 or D1S7) showed a random loss of the parental 1p homologues (P = 0.59), contrary to the expected preferential maternal 1p deletion if an imprinted suppressor gene mapped to this region. However, 19 tumors with 1p LOH and single copy MYCN had deletion of the maternal 1p homologue preferentially (P = 0.02), which does not exclude the possibility that loss of an imprinted suppressor gene plays a role in this subset.
Similar articles
-
Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.Cancer Res. 1995 Dec 1;55(23):5681-6. Cancer Res. 1995. PMID: 7585654
-
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.Nat Genet. 1993 Jun;4(2):187-90. doi: 10.1038/ng0693-187. Nat Genet. 1993. PMID: 8102298
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
[Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].Verh K Acad Geneeskd Belg. 1995;57(5):389-422. Verh K Acad Geneeskd Belg. 1995. PMID: 8571670 Review. Dutch.
-
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.J Mol Diagn. 2000 Feb;2(1):37-46. doi: 10.1016/S1525-1578(10)60613-7. J Mol Diagn. 2000. PMID: 11272900 Free PMC article. Review.
Cited by
-
Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future.Cancers (Basel). 2021 Nov 24;13(23):5897. doi: 10.3390/cancers13235897. Cancers (Basel). 2021. PMID: 34885007 Free PMC article. Review.
-
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.Genes Dev. 2003 Feb 15;17(4):476-87. doi: 10.1101/gad.1040003. Genes Dev. 2003. PMID: 12600941 Free PMC article.
-
MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1α and p53 pathways.Sci Rep. 2016 Nov 8;6:36268. doi: 10.1038/srep36268. Sci Rep. 2016. PMID: 27824082 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical